These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 34845)

  • 1. Neuroleptic withdrawal dyskinesia [proceedings].
    Escobar JI; Tuason VB
    Psychopharmacol Bull; 1979 Apr; 15(2):71-4. PubMed ID: 34845
    [No Abstract]   [Full Text] [Related]  

  • 2. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.
    Thomas A; Onofrj M
    Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099
    [No Abstract]   [Full Text] [Related]  

  • 3. Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment.
    Connor DF; Benjamin S; Ozbayrak KR
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1490-4. PubMed ID: 8543517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life-threatening neuroleptic withdrawal emergent syndrome resembling status dystonicus.
    Pugin D; Bally J; Horvath J; Pollak P; Gasche Y; Burkhard PR
    Parkinsonism Relat Disord; 2017 Feb; 35():96-97. PubMed ID: 27914829
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
    Margetić B; Aukst-Margetić B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tardive akathisia and tardive dyskinesia].
    Fennig S; Helben J; Neumann M
    Harefuah; 1991 Jan; 120(2):71-2. PubMed ID: 1672523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 8. Early-onset tardive dyskinesia in a neuroleptic-naive patient exposed to low-dose quetiapine.
    Walsh RA; Lang AE
    Mov Disord; 2011 Oct; 26(12):2297-8. PubMed ID: 21735479
    [No Abstract]   [Full Text] [Related]  

  • 9. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible hyperkinetic movement disorder associated with quetiapine withdrawal.
    Ahmad MT; Prakash KM
    Mov Disord; 2010 Jul; 25(9):1308-9. PubMed ID: 20310037
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic-induced movement disorders: an overview.
    Sachdev PS
    Psychiatr Clin North Am; 2005 Mar; 28(1):255-74, x. PubMed ID: 15733622
    [No Abstract]   [Full Text] [Related]  

  • 13. [Late extrapyramidal hyperkinesis and neuroleptic withdrawal dyskinesia. Practical problems].
    Hoffmann C; Faust V
    Fortschr Med; 1983 Mar; 101(11):470-6. PubMed ID: 6133824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tardive dyskinesia induced by neuroleptics. A review of the literature].
    Diepart E; Cottereau MJ; Deniker P
    Encephale; 1979; 5(4):317-37. PubMed ID: 42528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic-induced supersensitivity psychosis, the "hump course," and tardive dyskinesia.
    Chovinard G; Jones B
    J Clin Psychopharmacol; 1982 Apr; 2(2):143-4. PubMed ID: 6122695
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic-withdrawal cachexia.
    Mikkelsen EJ; Albert LG; Upadhyaya A
    N Engl J Med; 1988 Apr; 318(14):929. PubMed ID: 2895425
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of spontaneous dyskinesia in schizophrenia.
    Fenton WS
    J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs.
    Kristjansen P
    Adv Biochem Psychopharmacol; 1980; 24():505-11. PubMed ID: 6105796
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversible withdrawal dyskinesia associated with quetiapine.
    Michaelides C; Thakore-James M; Durso R
    Mov Disord; 2005 Jun; 20(6):769-70. PubMed ID: 15747370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.